Literature DB >> 19319525

Amyloid imaging with PET: methodological issues and correlative studies.

Giovanni Lucignani1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19319525     DOI: 10.1007/s00259-009-1124-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

1.  Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?

Authors:  Jitka Sojkova; Lori Beason-Held; Yun Zhou; Yang An; Michael A Kraut; Weigo Ye; Luigi Ferrucci; Chester A Mathis; William E Klunk; Dean F Wong; Susan M Resnick
Journal:  J Nucl Med       Date:  2008-08-14       Impact factor: 10.057

2.  Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.

Authors:  Rebecca L McNamee; Seong-Hwan Yee; Julie C Price; William E Klunk; Bedda Rosario; Lisa Weissfeld; Scott Ziolko; Michael Berginc; Brian Lopresti; Steven Dekosky; Chester A Mathis
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

3.  Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

Authors:  Paul W Thompson; Liang Ye; Jennifer L Morgenstern; Lucia Sue; Thomas G Beach; Duncan J Judd; Nicholas J Shipley; Vincenzo Libri; Andrew Lockhart
Journal:  J Neurochem       Date:  2009-02-13       Impact factor: 5.372

4.  Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Authors:  Clayton A Wiley; Brian J Lopresti; Sriram Venneti; Julie Price; William E Klunk; Steven T DeKosky; Chester A Mathis
Journal:  Arch Neurol       Date:  2009-01

5.  Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.

Authors:  A Okello; P Edison; H A Archer; F E Turkheimer; J Kennedy; R Bullock; Z Walker; A Kennedy; N Fox; M Rossor; D J Brooks
Journal:  Neurology       Date:  2009-01-06       Impact factor: 9.910

6.  Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.

Authors:  Arthur Mikhno; Davangere Devanand; Gregory Pelton; Katrina Cuasay; Roger Gunn; Neil Upton; Robert Y Lai; Vincenzo Libri; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

Review 7.  Amyloid plaque imaging in vivo: current achievement and future prospects.

Authors:  Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

8.  [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.

Authors:  Marie M Svedberg; Håkan Hall; Ewa Hellström-Lindahl; Sergio Estrada; ZhiZhong Guan; Agneta Nordberg; Bengt Långström
Journal:  Neurochem Int       Date:  2008-12-30       Impact factor: 3.921

9.  Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Authors:  Milos D Ikonomovic; William E Klunk; Eric E Abrahamson; Chester A Mathis; Julie C Price; Nicholas D Tsopelas; Brian J Lopresti; Scott Ziolko; Wenzhu Bi; William R Paljug; Manik L Debnath; Caroline E Hope; Barbara A Isanski; Ronald L Hamilton; Steven T DeKosky
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

10.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Yi Li; Juha O Rinne; Lisa Mosconi; Elizabeth Pirraglia; Henry Rusinek; Susan DeSanti; Nina Kemppainen; Kjell Någren; Byeong-Chae Kim; Wai Tsui; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

View more
  1 in total

1.  Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.

Authors:  Eric A Tanifum; Indrani Dasgupta; Mayank Srivastava; Rohan C Bhavane; Li Sun; John Berridge; Hoda Pourgarzham; Rashmi Kamath; Gabriela Espinosa; Stephen C Cook; Jason L Eriksen; Ananth Annapragada
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.